GSK, CureVac's next-gen Covid-19 vaccine shows promise in monkey trial

GlaxoSmithKline and CureVac said a study on macaque monkeys showed their jointly-developed mRNA Covid-19 vaccine candidate to be "strongly improved" in protecting against the virus compared with CureVac's first attempt.

from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/3AJZrjE